ONWARD MEDICAL BV EO -12
Research ONWARD MEDICAL BV EO -12 (63E) on Bullrun: market cap EUR 163.74M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker63E
- ExchangeF
- CountryNetherlands
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 163.74M
- Financial periodFY2025
- RevenueEUR 3.78M
- Revenue growth1550.7%
- Net income-EUR 41.79M
- Free cash flow-EUR 39.50M
- Gross margin72.5%
Valuation Snapshot
latest market cap is EUR 163.74M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 3.78M | -EUR 41.79M | -EUR 39.50M | 72.5% | -0.9 | EUR 68.11M | EUR 13.67M | EUR 55.32M |
| FY2024 | EUR 229.00K | -EUR 35.73M | -EUR 31.91M | 90.4% | -0.8 | EUR 60.04M | EUR 15.09M | EUR 48.05M |
| FY2023 | EUR 68.00K | -EUR 36.18M | -EUR 32.69M | 100.0% | -1.2 | EUR 29.77M | EUR 16.87M | EUR 17.93M |
| FY2022 | EUR 104.00K | -EUR 32.77M | -EUR 27.10M | -14122.1% | -1.09 | EUR 41.76M | EUR 14.38M | EUR 52.63M |
| FY2021 | n/a | -EUR 34.31M | -EUR 19.97M | n/a | -3.62 | EUR 89.44M | EUR 11.45M | EUR 82.68M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-14 | EUR 163.74M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About ONWARD MEDICAL BV EO -12
Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with spinal cord injury (SCI) in the United States, Europe, and internationally. The company offers ARCEX System, an external stimulator that is intended to improve hand strength and sensation following SCI; ARCIM System, an implantable system currently used to explore potential indications in clinical feasibility studies;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is ONWARD MEDICAL BV EO -12's market cap?
ONWARD MEDICAL BV EO -12's market capitalization is EUR 163.74M.
What does ONWARD MEDICAL BV EO -12 do?
Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with spinal cord injury (SCI) in the United States, Europe, and internationally. The company offers ARCEX System, an external stimulator that is intended to improve hand strength and sensation following SCI; ARCIM System, an implantable system currently used to explore potential indications in clinical feasibility studies; ARCBCI System, an implantable system currently being investigated to enable thought driven movement of the legs and upper extremities.